background
porcin
epidem
diarrhea
viru
pedv
emerg
pathogen
coronaviru
caus
huge
econom
burden
swine
industri
interact
viral
spike
surfac
glycoprotein
host
cell
receptor
recogn
first
step
infect
main
determin
viru
tropism
mechan
neutral
antibodi
inhibit
pedv
defin
isol
pedv
neutral
antibodi
crucial
identifi
receptorbind
domain
viral
spike
elucid
mechan
protect
pedv
infect
method
b
cell
hybridoma
techniqu
use
gener
hybridoma
cell
secret
specif
antibodi
ecoli
prokaryot
express
system
bactobac
express
system
use
identifi
target
protein
monoclon
antibodi
qpcr
perform
analyz
pedv
bind
vero
cell
neutral
antibodi
result
identifi
monoclon
antibodi
use
hybridoma
technolog
remark
mab
design
neutral
viru
infect
potent
target
conform
epitop
pedv
protein
qpcr
result
show
block
viru
entri
vero
cell
conclus
data
suggest
pedv
neutral
antibodi
inhibit
viru
infect
bind
infecti
virion
could
work
tool
find
receptorbind
domain
porcin
epidem
diarrhea
viru
pedv
belong
alphacoronaviru
genu
coronavirida
famili
etiolog
agent
porcin
epidem
diarrhea
ped
caus
enter
diseas
affect
age
swine
clinic
present
complic
infect
character
acut
vomit
dehydr
wateri
diarrhea
high
mortal
suck
piglet
indistinguish
infect
either
transmiss
gastroenter
viru
tgev
porcin
enter
alphacoronaviru
peav
first
detect
uk
pedv
result
mass
epidem
within
europ
ped
preval
asia
europ
spring
howev
ped
outbreak
reach
north
america
due
variant
pedv
strain
research
reveal
might
deriv
chines
variant
spite
widespread
immun
current
market
vaccin
ped
still
persist
swine
rais
countri
result
devast
damag
pork
produc
pedv
envelop
singlestrand
rna
coronaviru
kb
genom
includ
open
read
frame
encod
spike
envelop
e
membran
nucleocapsid
n
well
open
read
frame
encod
replicas
known
coronavirus
three
pedv
glycoprotein
form
clubshap
function
trimer
local
surfac
virion
mediat
essenti
biolog
function
membran
fusion
receptor
bind
protein
also
respons
induct
nab
protect
immun
make
appropri
candid
develop
effect
vaccin
diagnost
reagent
addit
variat
gene
lead
antigen
divers
thu
protein
use
evalu
genet
divers
littl
known
compon
immun
system
effect
protect
pig
pedv
infect
quantiti
nab
gener
vaccin
correl
degre
protect
mani
diseas
consid
signific
nab
provid
protect
understand
mechan
neutral
necessari
develop
vaccin
elicit
strong
nab
fragment
antigenbind
fab
domain
bind
specif
pathogen
target
prevent
microbi
interact
host
cell
receptor
thu
block
infect
protect
nab
result
block
interact
free
viru
particl
target
cell
receptor
addit
nab
infect
block
inhibit
critic
intracellular
process
exampl
rotaviru
transcript
nuclear
transloc
human
papilloma
viru
dna
adenovir
uncoat
measl
viru
assembl
sever
studi
demonstr
spike
mab
neutral
pedv
studi
mainli
focus
locat
neutral
domain
pedv
protein
howev
mechan
spike
nab
neutral
viru
defin
complet
fill
knowledg
gap
gener
four
mab
exhibit
potent
neutral
activ
pedv
vitro
notabl
found
block
pedv
entri
vero
cell
vero
cell
line
cultur
maintain
dmem
contain
fb
antibiot
uml
penicillin
streptomycin
solarbio
beij
china
insect
cell
line
maintain
suspens
serumfre
medium
spinner
flask
speed
rpm
propag
vero
cell
trypsin
pedv
strain
use
studi
indic
strain
unless
otherwis
note
pedv
propag
purifi
previous
describ
briefli
vero
cell
wash
twice
phosphat
buffer
salin
pb
remov
residu
dmem
follow
h
incub
pedv
wash
pb
next
cell
infect
viru
via
addit
dmem
contain
trypsin
cell
harvest
h
infect
cell
show
characterist
cytopathogen
effect
three
cycl
freezethaw
done
releas
intracellular
viru
particl
centrifug
g
perform
pellet
cellular
debri
clarif
supernat
enrich
time
ultracentrifug
g
purifi
sucros
densiti
gradient
centrifug
use
sucros
solut
ww
ww
w
w
respect
purifi
product
analyz
sdspage
western
blot
standard
procedur
use
gener
hybridoma
cell
secret
pedvspecif
antibodi
modif
briefli
femal
balbc
mice
week
immun
purifi
pedv
inactiv
complet
freund
adjuv
sigma
st
loui
mo
usa
mous
immun
purifi
pedv
contain
spike
protein
determin
sdspage
gray
scan
two
booster
immun
administ
interv
pedv
incomplet
freund
adjuv
sigma
st
loui
mo
usa
next
mice
sacrif
follow
booster
inocul
intraperiton
inject
vv
sigma
st
loui
mo
usa
use
fusion
spleen
cell
immun
mice
myeloma
cell
hybridoma
cell
cultur
plate
hat
sigma
st
loui
mo
usa
screen
cultur
medium
posit
hybridoma
clone
pick
indirect
immunofluoresc
assay
ifa
follow
clone
via
limit
dilut
least
three
round
polyclon
antibodi
pedv
taken
posit
control
normal
mous
serum
taken
neg
control
mous
monoclon
antibodi
isotyp
reagent
sigma
st
loui
mo
usa
use
identif
subtyp
mab
secret
final
hybridoma
clone
ascit
fluid
collect
prime
balbc
mice
paraffin
oil
purifi
use
protein
g
fast
flow
ge
healthcar
pittsburgh
usa
accord
manufactur
instruct
purifi
mab
quantifi
bca
kit
thermo
fisher
usa
supernat
hybridoma
cell
cultur
screen
presenc
pedvspecif
mab
ifa
primari
vero
cell
grown
confluenc
well
plate
infect
h
multipl
infect
moi
fixat
paraformaldehyd
monolay
permeabil
triton
follow
h
incub
supernat
hybridoma
cell
unbound
antibodi
remov
wash
pb
specif
mab
detect
affinipur
goat
antimous
igg
h
l
proteintech
rosemont
usa
order
determin
conform
epitop
bound
mab
main
structur
protein
pedv
includ
sp
partli
gene
fragment
n
express
bactobac
express
system
invitrogen
carlsbad
ca
follow
manufactur
instruct
cell
infect
recombin
baculoviru
moi
follow
fixat
permeabil
incub
supernat
hybridoma
cell
day
later
reactiv
mab
recombin
protein
measur
ifa
order
determin
linear
epitop
bound
mab
truncat
sp
full
length
n
gene
also
clone
detail
truncat
sp
protein
refer
previou
studi
recombin
dna
use
transform
cell
follow
protein
express
refer
manufactur
instruct
nichel
sepharos
fast
flow
ge
usa
use
purif
protein
affin
chromatographi
purifi
protein
quantifi
bca
kit
thermo
fisher
usa
reaction
mab
truncat
sp
n
protein
evalu
elisa
briefli
plate
griener
germani
coat
purifi
protein
ng
overnight
block
milk
h
wash
three
time
pb
supernat
ad
sampl
incub
h
subsequ
plate
wash
pb
incub
hrpconjug
goat
antimous
igg
proteintech
usa
h
absorb
measur
nm
sampl
repeat
three
time
sampl
consid
posit
relat
od
sampleod
neg
control
higher
determin
whether
antibodi
neutral
activ
conduct
viru
neutral
test
previous
describ
modif
briefli
min
inactiv
test
mab
dilut
filter
use
membran
follow
twofold
serial
dilut
pedv
strain
titer
ml
mix
dilut
mab
equal
volum
mixtur
ad
trypsin
follow
h
incub
next
vero
cell
monolay
plate
cultur
mixtur
ml
h
adsorpt
inocula
discard
next
plate
wash
three
time
pb
dmem
trypsin
ad
well
plate
incub
h
plaqu
color
neutral
red
serumneutr
sn
titer
determin
accord
highest
mab
dilut
led
inhibit
format
viral
plaqu
complet
neutral
calcul
use
follow
formula
plaqu
countsneg
control
count
determin
whether
could
neutral
infect
ifa
neutral
assay
perform
mab
incub
equal
volum
tcid
ml
pedv
h
sampleviru
mixtur
transfer
duplic
well
plate
contain
confluent
vero
cell
plate
incub
h
wash
gentli
pb
remov
unbound
virus
follow
h
incub
co
atmospher
pedvinfect
cell
fix
paraformaldehyd
analys
ifa
use
detect
antibodi
viru
infect
presenc
absenc
antibodi
quantifi
previous
describ
slight
modif
dilut
antibodi
mix
pedv
equal
volum
follow
h
incub
next
mixtur
antibodyviru
ad
triplic
well
confluent
vero
cell
monolay
h
infecti
adsorpt
analyz
pedv
nab
bind
two
differ
time
point
pedv
incub
vero
cell
one
hour
follow
addit
antibodi
h
incub
trypsin
ad
throughout
experi
cell
wash
twice
pb
collect
measur
cellassoci
pedv
via
viral
rna
rtqpcr
briefli
cell
well
obtain
centrifug
rpm
min
rna
extract
cell
use
trizol
reagent
invitrogen
usa
cdna
synthes
rna
use
rtpcr
kit
takara
china
specif
primer
sens
antisens
probe
design
amplifi
detect
n
gene
pedv
realtim
pcr
assay
carri
reaction
mixtur
contain
thunderbird
probe
qpcr
mix
cdna
templat
rox
refer
dye
probe
primer
pcr
amplif
perform
appli
biosystem
fast
instrument
life
technolog
usa
follow
condit
initi
denatur
follow
cycl
tenfold
serial
dilut
standard
plasmid
tn
rang
test
five
replic
realtim
rtpcr
gener
standard
curv
nineti
sixwel
plate
griener
frickenhausen
germani
firstli
coat
pedv
densiti
virionswel
overnight
follow
h
block
bsa
wash
pb
three
time
ad
dilut
mab
sampl
incub
h
next
plate
rins
pb
cultur
h
mab
label
horseradish
peroxidas
ezlink
maleimid
activ
horseradish
peroxidas
kit
thermo
scientif
usa
react
result
visual
use
tramethylbenzidin
tmb
stop
hcl
sampl
repeat
three
time
absorb
determin
use
micropl
reader
biotek
nm
pedv
concentr
enrich
fold
purifi
sucros
densiti
gradient
centrifug
purifi
product
analyz
sdspage
western
blot
result
show
main
structur
protein
reserv
ultracentrifug
see
addit
file
figur
balbc
mice
immun
purifi
pedv
ten
mab
prepar
via
lymphocyt
hybridoma
techniqu
could
react
well
pedvinfect
vero
cell
ifa
shown
fig
syncytium
form
due
pedv
infect
cell
detect
use
neg
mous
serum
specif
stain
mous
polyclon
antibodi
mab
mab
determin
isotyp
except
isotyp
data
show
pedv
protein
identifi
target
pedv
nab
order
determin
whether
pedv
n
protein
recogn
mab
truncat
sp
fragment
full
length
n
amplifi
insert
transform
express
protein
purifi
use
nicolumn
coat
enzym
plate
per
well
elisa
result
demonstr
reactiv
n
protein
react
sp
protein
mab
nt
react
recombin
protein
fig
sp
n
gene
also
clone
pfastbac
vector
later
sequenc
result
verifi
express
plasmid
contain
sp
n
correct
direct
read
code
frame
respect
accord
ifa
analysi
recombin
protein
n
sp
success
express
cell
use
mous
antipedv
polyclon
serum
primari
antibodi
see
addit
file
figur
show
reactiv
sp
protein
reactiv
n
protein
reactiv
protein
neutral
activ
select
specif
mab
assess
prn
assay
mab
purifi
ascit
fluid
protein
g
dilut
work
concentr
pb
twofold
serial
dilut
nab
work
stock
test
triplic
prn
assay
shown
fig
complet
neutral
infect
vero
cell
work
concentr
respect
mab
neutral
input
virus
maximum
work
concentr
fig
mab
nt
abil
neutral
viru
order
evalu
neutral
effect
nab
differ
subtyp
virus
strongest
neutral
capac
chosen
test
inhibit
infect
ifa
use
n
protein
antibodi
strain
belong
subtyp
nt
form
plaqu
shown
fig
complet
suppress
infect
result
indic
abl
inhibit
infect
genogroup
pedv
explor
mab
neutral
pedv
infect
cell
test
lowest
concentr
incub
h
antibodi
mixtur
ad
vero
cell
h
postinfect
unbound
virus
wash
cellassoci
pedv
measur
rtqpcr
inhibit
viral
entri
cell
indic
effect
two
nab
mediat
block
viral
attach
cell
fig
nab
ad
vero
cell
separ
time
point
confirm
result
firstli
pedv
incub
vero
cell
h
allow
attach
viru
cell
surfac
without
enter
cell
rins
pb
remov
unattach
viru
subsequ
nab
ad
pedvcel
complex
temperatur
increas
initi
viral
fusion
h
nab
block
viral
attach
cell
prebind
pedv
cell
incub
nab
would
produc
baculoviru
express
shown
sp
partli
gene
fragment
encod
experi
repeat
two
time
repres
imag
shown
fig
viru
neutralizt
test
neutral
titer
antibodi
titer
assess
plaqu
reduct
assay
neg
serum
normal
mous
set
neg
control
b
cell
viral
inhibit
assay
detect
ifa
target
n
protein
set
second
antibodi
posit
group
use
neg
serum
neg
group
use
posit
serum
control
respect
graph
repres
mean
three
independ
experi
error
bar
indic
standard
deviat
prevent
neutral
addit
two
nab
pedv
attach
cell
reduc
cellassoci
pedv
fig
suggest
inhibit
infect
pedv
block
viru
attach
cell
downstream
process
exert
neutral
effect
directli
inhibit
test
virus
bind
infect
cell
determin
whether
antibodi
bind
epitop
fig
shown
competit
elisa
assay
compet
bind
pedv
data
indic
antibodi
bind
distinct
epitop
multipl
alphacoronavirus
tgev
prcov
felin
coronaviru
type
ii
human
coronaviru
use
aminopeptidas
n
apn
receptor
apn
univers
receptor
alphacoronavirus
human
coronaviru
use
angiotensin
convert
entri
present
believ
porcin
apn
act
function
pedv
receptor
howev
whether
papn
receptor
pedv
debat
year
intriguingli
vero
cell
line
use
isol
pedv
strain
nt
express
apn
infer
vero
cell
proteom
data
indic
receptor
may
involv
pedv
entri
cell
sialic
acid
isol
nab
inhibit
viru
attach
cell
surfac
could
help
identifi
pedv
receptor
studi
screen
mab
hybridoma
technolog
main
structur
protein
pedv
express
use
prokaryot
eukaryot
express
system
respect
immunogen
protein
whole
viru
particl
determin
target
protein
mab
challeng
prokaryot
express
system
express
product
without
modif
product
linear
protein
baculoviru
express
system
abil
express
product
glycosyl
phosphoryl
process
modif
translat
similar
natur
protein
recogn
express
sp
protein
specif
cell
bind
sp
protein
express
cell
recogn
express
n
protein
cell
nt
bind
n
protein
express
cell
result
indic
specif
recogn
conform
epitop
instead
linear
epitop
recogn
linear
epitop
reactiv
express
protein
possibl
recogn
trimer
protein
protein
coronaviru
neutral
antibodi
often
attribut
antibodi
occup
trimer
interf
viral
attach
target
cell
entri
addit
neutral
activ
exhibit
dosedepend
manner
high
effici
neutral
moder
neutral
ml
observ
clearli
defin
sp
domain
critic
pedv
interact
target
cell
antisp
mab
strongest
neutral
capac
select
explor
mechan
nab
previous
report
pedv
attach
pedv
first
incub
antibodi
h
ad
cell
h
infect
incub
attach
pedv
initi
incub
vero
cell
h
antibodi
ad
pedvcel
cultur
temperatur
increas
h
infect
incub
cellassoci
pedv
quantifi
viral
rna
rtqpcr
set
isotyp
control
b
comparison
epitop
nab
use
competit
elisa
test
use
competitor
use
neg
control
result
present
mean
sem
n
differ
consid
signific
p
valu
p
valu
indic
follow
p
p
enter
vero
cell
via
initi
endocyt
uptak
subsequ
viru
fuse
pedv
host
endosom
membran
viru
attach
cell
nt
fusion
cell
membran
found
antisp
mab
effici
bound
pedv
inhibit
viru
entri
cell
experi
design
twotim
point
viru
infect
cell
h
mab
ad
h
result
show
viru
could
invad
replic
cell
copi
viru
infectedcel
differ
regardless
presenc
antisp
mab
pedvneg
serum
howev
posit
serum
nt
prevent
prolifer
intracellular
virus
may
due
lack
mab
posit
serum
neutral
viru
insid
cell
interact
mab
make
mab
lose
abil
neutral
intracellular
may
exist
possibl
mechan
result
demonstr
viral
attach
target
cell
neutral
antisp
mab
nt
work
seem
pedv
infect
cell
appar
lower
regardless
antibodi
indic
pedv
effici
taken
cell
endocytosi
consist
viru
uptak
effici
endocytosi
observ
herp
simplex
viru
infect
epitop
target
complet
distinct
antisp
mab
may
least
two
mechan
involv
neutral
effect
directli
inhibit
bind
epitop
